Bhushan Sahay

Bhushan Sahay

Active Director Director DIN 07863109
DIN 07863109 First appointment Jun 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2017
Shareholding value •••• Premium profile

About Bhushan Sahay

Data last updated:

Bhushan Sahay is a Director at Palbik Pharma Private Limited (since 2017). The company operates in Trading. Palbik Pharma Private Limited reported revenue of ₹3.33 Cr (FY 2025).

DIN 07863109
Primary Designation Director
Industry Trading
First Appointment 29 Jun 2017
Oldest Company Age 15 yrs
Largest company Palbik Pharma Private Limited · ₹3.33 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Palbik Pharma Private Limited U51909JH2010PTC014481
Director29 Jun 20172010₹3.33 Cr (FY 2025)Active

Board colleagues of Bhushan Sahay

Directorship timeline

Open interactive timeline →
Palbik Pharma Private Limited
Premium access

Shareholding and investment profile for Bhushan Sahay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhushan Sahay

Bhushan Sahay currently holds 1 directorship: Palbik Pharma Private Limited (Director, since 29 Jun 2017, revenue ₹3.33 Cr (FY 2025)).

Bhushan Sahay was first appointed on 29 Jun 2017 as Director at Palbik Pharma Private Limited.

The current boards of Bhushan Sahay's companies include Bikash Kumar Singh (Palbik Pharma Private Limited), Gopal Nand Jha (Palbik Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available